Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive (MHE) editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Jon Bloom, M.D., co-founder and CEO of Podimetrics, about the evolving role of physicians in U.S. healthcare.

To help Medicare plans better manage members with high drug expenses, Prime Therapeutics has launched an AI-driven tool to help plans identify members likely to experience increases in pharmacy costs.

Dupixent shows potential as a treatment for atopic dermatitis, alopecia and vitiligo, targeting shared immune pathways for improved skin health.

Wykoff discussed treating geographic atrophy in patients with wet age-related macular degeneration and his presentation of the results of the COAST trial that was halted earlier this year.

Managing specialty and cancer drugs, as well as the GLP-1 therapies, tops the list of priorities this year and next, according to a survey by the International Foundation of Employee Benefit Plans.

According to the American Cancer Society, about 22,000 new esophageal cancer cases were diagnosed in 2025 in the U.S., and over 16,000 deaths were attributed to the disease. Risk factors for this carcinoma include obesity, gastroesophageal reflux disease (GERD) and Barrett’s esophagus.

One paper compares aripiprazole, cariprazine and brexpiprazole for first-episode use. Another measures long-term outcomes for an aripiprazole monthly injectable.

Recent research confirms that aluminum in childhood vaccines does not increase the risk of autoimmune, allergic or neurodevelopmental disorders.

Switching to rFVIIIFc significantly reduces bleeding rates and injection frequency for hemophilia A patients, enhancing treatment efficacy and quality of life.

Postmenopausal women who sit less may have better heart health outcomes than those who sit for longer periods of time, according to a recent study published in Circulation.

Pharmacists and prescribers express ongoing concern about medication prior authorization struggles, but most are willing to adopt new technologies to ease the burden, according to a recent Surescripts survey.

Hidradenitis suppurativa patients face higher depression and anxiety risks, but biologic treatments may reduce these mental health challenges.

Brinsupri is the first approved therapy to address the underlying inflammatory process of non-cystic fibrosis bronchiectasis (NCFB).

Specialty drug spending rose 9.6% in 2024, but Humira biosimilar adoption is helping to slow cost increases.

HIV-fighting antibodies produced in infant macaques in a preclinical trial could be the future of HIV prevention in humans, according to Amir Ardeshir, Ph.D., DVM, Associate Professor of Microbiology and Immunology at Tulane University.

CEO Scott Staszak spoke to Managed Healthcare Executive about the creation of a patient registry and other accomplishments.

Originally approved earlier this year for multiple inflammatory conditions, including rheumatoid arthritis, giant cell arteritis, juvenile idiopathic arthritis and COVID-19-related inflammation, Avtozma now aligns fully with the FDA-approved indications of its biosimilar, Actemra.

Vice president of product and pharma contracting and strategy at Express Scripts

Early combination therapy could translate into fewer downstream hospitalizations and lower costs associated with dialysis and cardiovascular complications.

Here’s what you missed this week on Managed Healthcare Executive.

The American Society of Retina Specialists’ History of Retina is an initiative that highlights the milestones and the pioneers in ophthalmology and retinal disease treatment.

Senior vice president at CVS Caremark

The FDA's approval of Alhemo (concizumab-mtci) revolutionizes hemophilia treatment, offering a simpler, subcutaneous injection for better bleed control and patient independence.

A recent study found major racial disparities in U.S. prescription drug use, with White patients using the most and Black patients often undertreated.